{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:59:41Z","timestamp":1787950781613,"version":"build-2784847793"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":732,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle Nerve"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1002\/mus.23812","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T12:42:45Z","timestamp":1360327365000},"page":"716-721","source":"Crossref","is-referenced-by-count":9,"title":["Frequency and spectrum of myopathies in patients with psoriasis"],"prefix":"10.1002","volume":"48","author":[{"given":"Teerin","family":"Liewluck","sequence":"first","affiliation":[{"name":"Department of Neurology; University of Colorado Denver School of Medicine; Anschutz Medical Campus, 12631 East 17th Avenue Aurora Colorado 80045 USA"},{"name":"Department of Neurology; Mayo Clinic College of Medicine; Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floranne C.","family":"Ernste","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine; Mayo Clinic College of Medicine; Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Tracy","sequence":"additional","affiliation":[{"name":"Department of Neurology; Mayo Clinic College of Medicine; Rochester Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"10.1002\/mus.23812-BIB0001|mus23812-cit-0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions","volume":"65","author":"Menter","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/mus.23812-BIB0002|mus23812-cit-0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.2009.04380.x","article-title":"Introduction: arthritis and myositis","volume":"1154","author":"Katz","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1002\/mus.23812-BIB0003|mus23812-cit-0003","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10067-010-1467-6","article-title":"Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?","volume":"29","author":"Nagashima","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1002\/mus.23812-BIB0004|mus23812-cit-0004","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000252556","article-title":"The psoriatic myopathy","volume":"140","author":"Mom","year":"1970","journal-title":"Dermatologica"},{"key":"10.1002\/mus.23812-BIB0005|mus23812-cit-0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-4362.1984.tb04064.x","article-title":"Psoriatic myopathy","volume":"23","author":"Chase","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1002\/mus.23812-BIB0006|mus23812-cit-0006","first-page":"395","article-title":"Psoriatic arthritis and myopathy","volume":"17","author":"Thomson","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1002\/mus.23812-BIB0007|mus23812-cit-0007","first-page":"116","article-title":"Dermatomyositis associated with psoriasis","volume":"52","author":"Alekberova","year":"1980","journal-title":"Ter Arkh"},{"key":"10.1002\/mus.23812-BIB0008|mus23812-cit-0008","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2298\/VSP0405557P","article-title":"Psoriasis in a patient with dermatomyositis","volume":"61","author":"Pavlovic","year":"2004","journal-title":"Vojnosanit Pregl"},{"key":"10.1002\/mus.23812-BIB0009|mus23812-cit-0009","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1002\/mus.23812-BIB0010|mus23812-cit-0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archdermatol.2011.49","article-title":"Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis","volume":"147","author":"Kim","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1002\/mus.23812-BIB0011|mus23812-cit-0011","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jocn.2008.01.011","article-title":"Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis","volume":"15","author":"Needham","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1002\/mus.23812-BIB0012|mus23812-cit-0012","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2009.173823","article-title":"Inclusion body myositis: old and new concepts","volume":"80","author":"Amato","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/mus.23812-BIB0013|mus23812-cit-0013","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clineuro.2011.03.016","article-title":"The association of sporadic inclusion body myositis and Sjogren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype","volume":"113","author":"Rojana-Udomsart","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1002\/mus.23812-BIB0014|mus23812-cit-0014","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10067-009-1367-9","article-title":"Inclusion body myositis in patient with long standing rheumatoid arthritis treated with anti-TNF\u03b1 and rituximab","volume":"29","author":"Vordenbaumen","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1002\/mus.23812-BIB0015|mus23812-cit-0015","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2008.093161","article-title":"Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences","volume":"68","author":"Bernatsky","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/mus.23812-BIB0016|mus23812-cit-0016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10067-011-1895-y","article-title":"Risk of lymphoma in patients receiving antitumor necrotic factor therapy: a meta-analysis of published randomized controlled studies","volume":"31","author":"Wong","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1002\/mus.23812-BIB0017|mus23812-cit-0017","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1002\/mus.23812-BIB0018|mus23812-cit-0018","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.22279","article-title":"Necrotizing myopathy: clinicoserologic associations","volume":"45","author":"Ellis","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1002\/mus.23812-BIB0019|mus23812-cit-0019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1002\/mus.23812-BIB0020|mus23812-cit-0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methyglutaryl-coenzyme A reductase (HMGCR) in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1002\/mus.23812-BIB0021|mus23812-cit-0021","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/1042819021000016186","article-title":"Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Saif","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1002\/mus.23812-BIB0022|mus23812-cit-0022","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/01.wnl.0000180362.90078.dc","article-title":"Sporadic late onset nemaline myopathy","volume":"25","author":"Chahin","year":"2005","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1002\/mus.23812-BIB0023|mus23812-cit-0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/1153414-S0-000000000-00000","article-title":"Psoriasis: targeting therapy towards the inflammatory cascade","volume":"11","author":"Miteva","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1002\/mus.23812-BIB0024|mus23812-cit-0024","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1002\/mus.23812-BIB0025|mus23812-cit-0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/ard.2008.095984","article-title":"Chemokines and dendritic cells in inflammatory myopathies","volume":"68","author":"Tournadre","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/mus.23812-BIB0026|mus23812-cit-0026","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1002\/mus.23812-BIB0027|mus23812-cit-0027","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/mus.23812-BIB0028|mus23812-cit-0028","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1529-8019.2010.01304.x","article-title":"Epidemiology of comorbidities in psoriasis","volume":"23","author":"Naldi","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1002\/mus.23812-BIB0029|mus23812-cit-0029","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Muscle & Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.23812","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mus.23812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:30:55Z","timestamp":1625459455000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.23812"}},"subtitle":["Myopathies in Psoriasis Patients"],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"URL":"https:\/\/doi.org\/10.1002\/mus.23812","relation":{},"ISSN":["0148-639X"],"issn-type":[{"value":"0148-639X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}